MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Pathologist

  • November 4, 2026
Faster Genomic Testing for Children With Cancer
  • Helen Bristow
  • November 4, 2026
  • 3 min

Objective: The article reports on Addenbrooke’s Hospital’s use of rapid whole-genome sequencing (WGS) for children suspected of having cancer and discusses how

...more

The Pathologist

  • November 4, 2026
Colorectal Cancer Diagnosed Too Late in Youth
  • November 4, 2026
  • 2 min

Objective: To describe disease stage, symptoms, tumor characteristics, recurrence, and outcomes among patients aged 21 or younger diagnosed with colorectal canc

...more
2 min

The Medicine Maker

  • November 4, 2026
Who Funds Biotech Shapes What Gets Built
  • Kathryn Wighton
  • James Strachan
  • November 4, 2026
  • 11 min

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

The Medicine Maker

  • November 4, 2026
Naive-Like T Cells Linked to CAR T Durability
  • November 4, 2026
  • 3 min

Objective: Assess whether CAR T cell product characteristics are associated with outcomes in patients with non-Hodgkin lymphoma. Approach: Primary analysis: Res

...more
2 min

The Pathologist

  • November 3, 2026
Patient Clinics in Pathology's Evolution
  • Michele Mitchell
  • November 3, 2026
  • 4 min

Objective: Argue that pathology explanation clinics—where pathologists discuss findings directly with patients—deserve recognition as part of pathology’s ongoin

...more
2 min

MDSpire News

  • November 3, 2026
Upadacitinib may improve scalp hair regrowth
  • Andrea Surnit
  • November 3, 2026
  • 4 min
  1. Two phase 3 trials randomized 1,399 patients aged 12 to under 64 years with severe alopecia areata to upadacitinib 15 mg, 30 mg, or placebo for 24 weeks.
  2. At week 24, 45% of patients receiving 15 mg and 54% to 55% receiving 30 mg achieved a SALT score of 20 or less, compared with 2% to 3% receiving placebo.
  3. Complete scalp hair regrowth at week 24 occurred in 13% to 14% of patients receiving 15 mg and 20% to 23% receiving 30 mg, versus 0% to 1% receiving placebo.
  4. Upadacitinib also improved eyebrow and eyelash regrowth, patient-reported disease status, symptoms, daily activity interference, and quality-of-life measures.
  5. During 24 weeks, adverse events occurred in 63% of patients receiving 15 mg, 67% receiving 30 mg, and 57% receiving placebo; no new safety signals or deaths were reported.
...more

MDSpire News

  • November 3, 2026
AI may cut breast biopsy review time by 44%
  • Andrea Surnit
  • November 3, 2026
  • 3 min

Objective: To compare pathologist review time and diagnostic performance with standard digital pathology versus AI-assisted digital pathology for breast biopsie

...more

Keck Medicine of USC

  • November 3, 2026
Meet Fernando Fleischman, MD
  • November 3, 2026
  • 3 min
  1. Fernando Fleischman, MD, is a cardiac surgeon and co-director of the USC George and Meryl Young Aortic Center.
  2. Fleischman specializes in minimally invasive endovascular techniques.
  3. Fleischman says his father, a surgeon and later a family physician, inspired his career in medicine.
  4. He values the collaborative atmosphere at Keck Medicine, where faculty and staff share ideas to determine what is best for patients.
  5. Fleischman says the aortic center receives complex and unusual cases from across the country.
...more

Keck Medicine of USC

  • November 3, 2026
Multidisciplinary Clinic Offers a New Model for Complex AFib Care
  • November 3, 2026
  • 5 min

Objective: The article examines the objective, findings, and clinical context described in Multidisciplinary Clinic Offers a New Model for Complex AFib Care. Ap

...more
3 min

MDSpire News

  • November 3, 2026
Pediatric corneal data show geographic gaps
  • Andrea Surnit
  • November 3, 2026
  • 4 min

Objective: To review pediatric reference data for corneal thickness, curvature, and diameter, including demographic variation, geographic representation, and me

...more
2 min

MDSpire News

  • November 3, 2026
Teen girls overtake boys in vaping
  • Andrea Surnit
  • November 3, 2026
  • 4 min
  1. Researchers analyzed 8 waves of nationally representative US data on adolescents aged 12 to 17 years from October 2014 through December 2024.
  2. Among adolescents aged 15 to 17 years, established vaping prevalence rose among girls from 4.9% in 2021 to 7.8% in 2024, while boys’ prevalence remained near 4.2% to 4.6%.
  3. In 2024, established vaping prevalence among adolescents aged 12 to 14 years was 1.5% among girls and 1.1% among boys.
  4. Established combustible cigarette smoking prevalence declined from 1.6% in 2014 to 2015 to 0.2% in 2024.
  5. The repeated cross-sectional design, self-reported nicotine use, and focus on established use limited conclusions about individual trajectories, causes, and experimentation.
...more

Baptist Health South Florida

  • November 3, 2026
Erin Gillaspie, M.D. M.P.H., Joins Baptist Health Herbert Wertheim Cancer Institute as Chief of Thoracic Surgery
  • November 3, 2026
  • 3 min

Objective: Announce Dr. Erin Gillaspie’s appointment as chief of thoracic surgery and summarize her professional background and research interests. Approach: Ap

...more
2 min

The Pathologist

  • November 3, 2026
ASCP 2026: Mentoring Across International Borders
  • November 3, 2026
  • 3 min
  1. Mohamed Abdelmonem and Marion Carrillo preview 2 interactive round tables at the ASCP Annual Meeting in November in Montréal.
  2. One round table will discuss how ASCP can make global membership more valuable, accessible, and relevant to international members.
  3. Speakers cite finances, education access, language, technology, professional recognition, local regulations, and health care system differences as participation barriers.
  4. The mentorship discussion will address cultural responsiveness, language, professional expectations, career pathways, and differences in laboratory medicine across countries.
  5. The sessions will use discussion, real-world examples, audience polling, and open dialogue to identify challenges and develop practical solutions.
...more

The Pathologist

  • November 3, 2026
Prognostic Biomarkers for Chagas Disease
  • November 3, 2026
  • 2 min

Objective: To identify blood metabolites associated with future cardiac disease progression in people with chronic Chagas disease. Approach: Study samples: Rese

...more
1 min

The Analytical Scientist

  • November 3, 2026
The Big Challenges: Part One – People, Resources, Reach
  • November 3, 2026
  • 11 min

Get quick, clinically relevant Q&A that turns long-form articles into clear answers for faster learning and discovery.

Take the Quiz

The Analytical Scientist

  • November 3, 2026
A New Interface for Longer-Lasting Batteries
  • November 3, 2026
  • 3 min
  1. Researchers coated a three-dimensional nanotubular copper current collector with an approximately 10-nm layer of Ti₃C₂Tₓ MXene for anode-free lithium-metal batteries.
  2. The MXene coating interacted with electrolyte hexafluorophosphate anions and promoted uniform lithium nucleation and a lithium fluoride-rich solid-electrolyte interphase.
  3. X-ray photoelectron spectroscopy, time-of-flight secondary ion mass spectrometry, and transmission electron microscopy characterized the interface and showed lithium fluoride nanoparticles along the M
  4. In lean-electrolyte coin cells with NCM811 cathodes, modified collectors retained 78.1 mAh/g at cycle 125, compared with 44.9 mAh/g for unmodified copper.
  5. At cycle 125, Coulombic efficiency was 99.06% with the modified collector and 95.01% with unmodified copper; larger-format testing remains necessary to assess commercial performance.
...more

The Analytical Scientist

  • November 3, 2026
Last Orders for Drug Residues?
  • November 3, 2026
  • 3 min

Objective: Assess whether atmospheric pressure solids analysis probe mass spectrometry (ASAP-MS) can rapidly screen surfaces for illicit drug residues, compared

...more

MDSpire News

  • November 3, 2026
May long COVID improve without full recovery?
  • Andrea Surnit
  • November 3, 2026
  • 4 min

Objective: To estimate how often adults with likely long COVID improve or achieve complete symptom resolution over time. Approach: Study design: Prospective obs

...more
2 min